The hiring of a former top FDA official amplifies "revolving door" criticism at the worst possible time, STAT's Adam ...
The federal crackdown on DEI initiatives is unlikely to deter companies from designing more representative trials, as it’s ...
But the direct-to-consumer ad didn't come from Palo Alto-based Bridge Bio (Nasdaq: BBIO); instead it was produced by Pfizer ...
Pfizer said on Thursday it will stop global development and commercialization of its hemophilia gene therapy, Beqvez, citing ...
The partners will test Summit’s ivonescimab alongside Pfizer’s antibody-drug conjugates in hopes of finding “potentially ...
The Trump administration has started rehiring some of the FDA employees it fired last week, the latest chapter in a haphazard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results